21
Participants
Start Date
June 1, 2019
Primary Completion Date
October 6, 2021
Study Completion Date
October 6, 2021
CYT107
IV twice a week at 10µg/kg for 3 weeks
Placebos
IV twice a week at the same volume for 3 weeks
CHU Dijon Bourgogne, Dijon
Chru Bretonneau, Tours
Chr Orleans, Orléans
CHU Angers, Angers
Washington University School of Medicine, St Louis
Hôpital Edouard Herriot, Lyon
Hopital COCHIN, Paris
University Hospital of Limoges, Limoges
Hopital HENRI MONDOR, Créteil
University of Florida, Gainesville
Collaborators (1)
Washington University School of Medicine
OTHER
University Hospital, Limoges
OTHER
Emerald Clinical Inc.
INDUSTRY
Revimmune
INDUSTRY